IPSE'S AUTHORS LAST 24h
Check all the Authors in the last 24h
IPSEs IN THE LAST 24H
  • Rina Shah
    Rina Shah “Protests in US universities are a display of democracy in action, a welcome sight in an election year marked by concerns of voter apathy chiefly due to Israel's war on Gaza. So when I see a movement like this of students taking peaceful, non-violent action and expressing their concern about the US government backing of Israel, of where our tax money is going, I think that's extremely healthy. These students are out there concerned about America's role in backing Benjamin Netanyahu. On the one hand, we are supplying weapons and funds to do what he wants to do in Gaza, while on the other we are sending humanitarian aid to Gaza. This is the hypocrisy these students are concerned about.” 2 hours ago
  • Thomas Friedman
    Thomas Friedman “But revenge is not a strategy. It is pure insanity that Israel is now more than six months into this war and the Israeli military leadership - and virtually the entire political class - has allowed Netanyahu to continue to pursue a 'total victory' there, including probably soon plunging deep into Rafah, without any exit plan or Arab partner lined up to step in once the war ends. If Israel ends up with an indefinite occupation of both Gaza and the West Bank, it would be a toxic military, economic and moral overstretch that would delight Israel's most dangerous foe, Iran, and repel all its allies in the West and the Arab world.” 2 hours ago
  • Volodymyr Zelenskiy
    Volodymyr Zelenskiy “Of course, I'm grateful to all of our partners who have helped us with air defence: each air defence system and each air defence missile is literally saving lives. It's important that everything works out as quickly as possible: every new agreement with our partners to strengthen our air defence, every initiative from Ukraine's friends to help us, particularly with finding and supplying Patriot [anti-aircraft missile systems]. Ukraine needs at least seven [Patriot] systems. Our partners have these Patriots. Russian terrorists can see that unfortunately our partners aren't as determined to protect Europe from terror as they are to do so in the Middle East. But [our partners] can give us the air defence systems that we need. We mustn't waste time: we need to signal determination.” 6 hours ago
  • Antony Blinken
    Antony Blinken “I saw that Huawei just put out a new laptop that it boasted was AI capable, that uses an Intel chip. I think it demonstrates that what we're focused on is only the most sensitive technology that could pose a threat to our security. We're not focused on cutting off trade, or for that matter containing or holding back China.” 11 hours ago
View All IPSEs inserted in the Last 24h
NEW CONTEXTS IN THE LAST 24H
  • No New Contexts inserted in the last 24 hours
View All New Contexts inserted in the last 24h

Battle to fight Covid-19

Page with all the IPSEs stored in the archive related to the Context Battle to fight Covid-19.
The IPSEs are presented in chronological order based on when the IPSEs have been pronounced.

“As the virus pushes at us, we must push back. We're in a much better position than at the beginning of the pandemic. Of course, there's been a lot of progress. We have safe and effective tools that prevent infections, hospitalisations and deaths. However, we should not take them for granted.”

author
Director-General of the World Health Organization
Read More

“I agree with the easing of restrictions, because you can't think of it as an emergency after two years. We just have to avoid thinking that COVID is no longer there. And therefore maintain the strictly necessary measures, which are essentially the continuous monitoring and tracking of cases, and the maintenance of the obligation to wear a mask in closed or very crowded places.”

author
Professor of immunology at Italy's University of Padua
Read More

“Our expectation is that the acute phase of this pandemic will end this year, of course with one condition, the 70 percent vaccination [target is achieved] by mid this year around June, July. If that is to be done, the acute phase can really end, and that is what we are expecting. It's in our hands. It's not a matter of chance. It's a matter of choice.”

author
Director-General of WHO
Read More

“Based on data from Denmark, the first country where BA.2 overtook BA.1, there appears to be no difference in disease severity, although BA.2 has the potential to replace BA.1 globally. Looking at other countries where BA.2 is now overtaking, we're not seeing any higher bumps in hospitalization than expected. The subvariant is already becoming dominant in the Philippines, Nepal, Qatar, India and Denmark. Vaccination is profoundly protective against severe disease, including for Omicron. BA.2 is rapidly replacing BA.1. Its impact is unlikely to be substantial, although more data are needed.”

author
WHO's COVID-19 Response Team
Read More

“There had been an argument about zero Covid and trying to eliminate the virus through restrictions. I think that we've lost that argument. I think that by allowing it to spread to the extent it has, it will be very, very difficult to put the genie back into the bottle. From that perspective we're going to have to live with it being endemic. But endemic doesn't mean not serious.”

author
Former chair of the British Medical Association's Public Health Medicine Committee
Read More

“A Conservative prime minister trying to deal in a responsible way with Covid is very different than a Democratic president trying to deal responsibly with Covid. From both a medical perspective and a political perspective there's not as strong an imperative for people to hunker down in the way they were hunkering down a year ago.”

author
Democratic pollster in Washington
Read More

“A week into the fourth dose we know to a higher degree of certainty that the fourth dose is safe. The second piece of news: We know that a week after administration of a fourth dose, we see a five-fold increase in the number of antibodies in the vaccinated person. This most likely means a significant increase against infection and …hospitalization and (severe) symptoms.”

author
Israeli Prime Minister
Read More

“The question is: is this going to be like influenza - against which an annual vaccine is recommended - or is it going to be like measles? - which requires only two doses for life-long protection. That's where many of us disagree.”

author
Professor at the University of Michigan’s school of public health
Read More

“The unvaccinated are much more likely to be in a hospital, and they're much more likely to be taking up a bed that might be wanted this winter.”

author
Epidemiologist at the Harvard T.H. Chan School of Public Health
Read More

“We have data out of the UK that suggests that there may be an intrinsic mildness to Omicron as compared to Delta but it's not by a lot, and the hyper contagiousness of Omicron means that even that mildness probably won't protect the health care system. So that is why we have to curtail transmission as much as we can. A tiny fraction of a large number, is still going to be a very large number.”

author
Epidemiologist and Science Communicator specializing in Global Health
Read More

“Unfortunately these measures are very little and I think are highly unlikely to do much at all to stem the tide of infections...and unfortunately with something that transmits as quickly as Omicron you have to move immediately because anything less than that and the transmission of the infection is going to outpace your efforts, it's sad but it's a mathematical fact.”

author
Infectious disease specialist at the Jewish General Hospital and an assistant professor at McGill University in Montreal
Read More

“There are many of these parties that have 30, 40, 50 people in which you do not know the vaccination status of individuals. Those are the kind of functions in the context of Omicron that you do not want to go to.”

author
Top US infectious disease expert
Read More

“Blanket booster programmes are likely to prolong the Covid-19 pandemic, rather than ending it, by diverting supply to countries that already have high levels of vaccination coverage, giving the virus more opportunity to spread and mutate. No country can boost its way out of the pandemic.”

author
Director-General of the World Health Organization
Read More

“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”

author
Director of the FDA's Center for Drug Evaluation and Research
Read More

“The efficacy is high, the side effects are low and it's oral. It checks all the boxes. You're looking at a 90 percent decreased risk of hospitalisation and death in a high-risk group - that's stunning.”

author
Professor of medicine at the Mayo Clinic in Rochester, Minnesota and director of the Mayo Clinic's Vaccine Research Group
Read More

“We're now at a point of having more than a billion doses a month of vaccines being produced, but it's a slow trickle still to get to low-income countries and lower middle-income countries. So we have not solved the supply challenge by any means, but we are closer to solving it than we ever have been. Looking forward to 2022 I think the entire game is really going to be about vaccination. So how do we get from airports to arms? How do we convert vaccines to vaccinations? I think we are woefully under-resourced and under-prepared for that … There's good progress to build from but much, much more work to do and financing gaps in the billions if not tens of billions of dollars.”

author
Founding director of the Global Health Innovation Center at Duke University in the US
Read More

“This is really about a harm reduction approach. So no matter what the new restrictions will be, there will be some who will not change their behaviour and want to see their family and friends. So wouldn't it be better to test and find COVID before the person enters the gathering or the event? We know that people's mental health has deteriorated and many people are emotionally burned out. So rapid antigen testing can be used to ease people's anxiety about whether they have COVID. It's not going to go away very quickly, this pandemic, so people need to start to feel more confident in going about their daily lives.”

author
Professor at the University of British Columbia's School of Nursing
Read More

“When I go to the store this afternoon, what helps me is to know how much COVID is in my community. There will not be one state of the pandemic. There will be different states for different people and for different regions. And that's going to be the way it is for the foreseeable future.”

author
Chair of the Department of Medicine at University of California, San Francisco
Read More

“Even if that immunity is not as good against Omicron, it doesn't mean that it's worthless. And that immunity is more effective against serious illness than it is against getting infected at all.”

author
Infectious disease epidemiologist at Johns Hopkins
Read More
IPSEs by Author
IPSEs by Country
arrow